The Patent Finder

Zengen, Inc.

Also on record
Records under this name other than patents Zengen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Zengen, Inc.

PatentTitleStatus Expires Confidence
US 9,561,182Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
Formerly held
Term ended
Term ended Aug 22, 2025 · From the USPTO record
Term endedTerm ended Aug 22, 2025From the USPTO record
US 10,398,644Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
Formerly held
Term ended
Term ended Nov 12, 2023 · From the USPTO record
Term endedTerm ended Nov 12, 2023From the USPTO record
US 6,800,291Uro-genital condition treatment system
Formerly held
Term ended
Ended no later than Mar 23, 2020 · From the USPTO record
Term endedEnded no later than Mar 23, 2020From the USPTO record
US 6,894,028Use of KPV tripeptide for dermatological disorders
Formerly held
Lapsed on the fee record
Ended May 17, 2017 · From the USPTO record
Lapsed on the fee recordEnded May 17, 2017From the USPTO record
US 7,244,710Treatment of ophthalmic infections using antimicrobial peptides
Formerly held
Lapsed on the fee record
Ended Jul 17, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jul 17, 2015From the USPTO record
US 7,232,804Use of KPV tripeptide for dermatological disorders
Formerly held
Lapsed on the fee record
Ended Jun 19, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jun 19, 2015From the USPTO record
US 7,115,574System and method for support legacy operating system booting in a legacy-free system
Formerly held
Lapsed on the fee record
Ended Oct 3, 2014 · From the USPTO record
Lapsed on the fee recordEnded Oct 3, 2014From the USPTO record
US 6,887,846Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
Formerly held
Lapsed on the fee record
Ended May 3, 2013 · From the USPTO record
Lapsed on the fee recordEnded May 3, 2013From the USPTO record
US 7,402,559Composition and method of treatment for urogenital conditions
Formerly held
Lapsed on the fee record
Ended Jul 22, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jul 22, 2012From the USPTO record
US 7,135,548Modified α-MSH peptides and derivatives thereof
Lapsed on the fee record
Ended Nov 14, 2010 · From the USPTO record
Lapsed on the fee recordEnded Nov 14, 2010From the USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited